ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

Recruiting

Phase 1

Phase 2

ATSN-201ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

Sponsor:

Atsena Therapeutics Inc.

Code:

NCT05878860

Conditions

X-linked Retinoschisis

Eligibility Criteria

Sex: Male

Age: 6+

Healthy Volunteers: Not accepted

Interventions

ATSN-201

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Atsena Therapeutics Inc. on 2025-02-19.